LONG MINI-FUTURE - MERCK & CO. | Market Closed - Deutsche Boerse AG 11:34:05 31/05/2024 pm IST | ||
| 3.32 EUR | -6.48% |
|
| 1 month | -14.65% | ||
| 3 months | -10.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 3.32 | -6.48% |
| 30/24/30 | 3.55 | +4.11% |
| 29/24/29 | 3.41 | +0.59% |
| 28/24/28 | 3.39 | -8.38% |
| 27/24/27 | 3.7 | -1.33% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 11:34 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM544E |
| ISIN | DE000VM544E9 |
| Date issued | 29/11/2023 |
| Strike | 89.66 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.1 € |
|---|---|
| Lowest since issue | 1.3 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
